Research Use Only · Not for Human Consumption · For Laboratory & Research Purposes
Home·Products·Tesamorelin
Tesamorelin

Tesamorelin

10 mg · 99.6% purity
$49.99Research Use Only

A 44-amino acid GHRH analog that stimulates pituitary gh secretion, studied for visceral adipose tissue reduction in clinical research.

Add to cart
✓ Third-party tested✓ Same-day shipping✓ Lyophilized · USA
Certificate of Analysis

Third-party tested, batch-by-batch

Every lot is independently verified for identity (MS), purity (HPLC), appearance, and endotoxin. View the summary for the current lot, or request the full signed PDF by email.

LOT A0326 · 10 mg
Identity (MS)Pass
Purity (HPLC)99.6%
Endotoxin< 0.1 EU/mg
AppearanceWhite lyophilate
Pairs Well

Frequently researched together

Compound Information

Technical specifications

Tesamorelin is a synthetic analogue of human Growth Hormone-Releasing Hormone (GHRH), a 44-amino acid hypothalamic peptide that stimulates pituitary somatotroph cells to secrete growth hormone (GH) via the GHRH receptor (GHRHR), a Gs-protein-coupled receptor. Unlike CJC-1295 (a truncated GHRH(1-29) analogue), tesamorelin retains the full 44-amino acid sequence of the endogenous hormone with an N-terminal trans-3-hexenoic acid modification that improves resistance to plasma dipeptidyl peptidase IV (DPP-IV) degradation. As a research compound, tesamorelin is used to study GHRH receptor binding kinetics, hypothalamic-pituitary GH axis signaling, and metabolic effects of GHRH receptor activation in preclinical and in vitro models.

Identity / Purity
99.6%
Format
Lyophilized powder
Size
10 mg
Lot
A0326
Origin
Synthetic analogue of endogenous Growth Hormone-Releasing Hormone (GHRH), retaining the full 44-amino acid active sequence with a trans-3-hexenoic acid modification at the N-terminus
Storage
−20°C, sealed
Key facts
  • Retains full 44-amino acid sequence of endogenous human GHRH, unlike CJC-1295 which is based on the truncated GHRH(1-29) fragment
  • N-terminal trans-3-hexenoic acid modification increases resistance to DPP-IV proteolytic cleavage compared to native GHRH
  • GHRH receptor (GHRHR) is a class B G-protein-coupled receptor expressed predominantly on pituitary somatotrophs; activation stimulates cAMP–PKA signaling and GH release
  • Endogenous GHRH is secreted in pulsatile fashion from the arcuate nucleus of the hypothalamus and is rapidly degraded in plasma (t½ < 5 min for native GHRH)
  • Studied in published clinical research for effects on visceral adipose tissue in the context of metabolic research; that research used pharmaceutical-grade formulations under clinical trial conditions, which are distinct from this RUO compound
  • Lyophilized; reconstituted with bacteriostatic water for in vitro or animal model studies
  • For research use only — not for human or veterinary administration
⚠️
For Research Use Only

All products sold by Next Level Research LLC are intended for laboratory and research use only. Not for human or animal consumption. Not a drug, food, or cosmetic. No therapeutic claims are made.